300760 迈瑞医疗
午间休市 05-15 11:30:00
资讯
新帖
简况
又有国际投行发声看好中国股市，外资一季度买了啥？
澎湃新闻 · 05-14 07:28
又有国际投行发声看好中国股市，外资一季度买了啥？
迈瑞医疗：2025年净利润率下降，其中最核心的影响因素是毛利率下降了
证券之星 · 05-13 17:21
迈瑞医疗：2025年净利润率下降，其中最核心的影响因素是毛利率下降了
迈瑞医疗 (300760) 递交香港 IPO 招股书
市场资讯 · 05-12 17:36
迈瑞医疗 (300760) 递交香港 IPO 招股书
新股消息 | 迈瑞医疗(300760.SZ)港股IPO招股书失效
智通财经 · 05-11
新股消息 | 迈瑞医疗(300760.SZ)港股IPO招股书失效
迈瑞医疗新注册《迈瑞数智运营管理软件V1.0》项目的软件著作权
证券之星 · 05-10
迈瑞医疗新注册《迈瑞数智运营管理软件V1.0》项目的软件著作权
新股消息 | 迈瑞医疗(300760.SZ)拟港股IPO 证监会要求补充说明本次募集资金用途等
智通财经 · 05-08
新股消息 | 迈瑞医疗(300760.SZ)拟港股IPO 证监会要求补充说明本次募集资金用途等
每周股票复盘：迈瑞医疗（300760）一季报净利降11.37%
证券之星 · 05-03
每周股票复盘：迈瑞医疗（300760）一季报净利降11.37%
迈瑞医疗公布国际专利申请：“样本分析仪、光度计和测光系统”
证券之星 · 05-02
迈瑞医疗公布国际专利申请：“样本分析仪、光度计和测光系统”
【机构调研记录】惠升基金调研迈瑞医疗
证券之星 · 04-30
【机构调研记录】惠升基金调研迈瑞医疗
迈瑞医疗最新公告：一季度净利润23.3亿元同比下降11.37%
证券之星 · 04-28
迈瑞医疗最新公告：一季度净利润23.3亿元同比下降11.37%
迈瑞医疗：公司中长期的战略方向是希望用未来十年时间进入全球前10名医疗器械公司的榜单
证券之星 · 04-22
迈瑞医疗：公司中长期的战略方向是希望用未来十年时间进入全球前10名医疗器械公司的榜单
迈瑞医疗：凭借丰富的并购整合经验降低商誉减值风险
证券之星 · 04-16
迈瑞医疗：凭借丰富的并购整合经验降低商誉减值风险
股市必读：迈瑞医疗（300760）4月15日董秘有最新回复
证券之星 · 04-16
股市必读：迈瑞医疗（300760）4月15日董秘有最新回复
迈瑞医疗：希望用未来十年时间进入全球前10名医疗器械公司的榜单
证券之星 · 04-15
迈瑞医疗：希望用未来十年时间进入全球前10名医疗器械公司的榜单
迈瑞医疗：4月9日高管李朝阳增持股份合计5000股
证券之星 · 04-10
迈瑞医疗：4月9日高管李朝阳增持股份合计5000股
迈瑞医疗：加快设备业务的数智化转型是公司业务发展战略
证券之星 · 04-10
迈瑞医疗：加快设备业务的数智化转型是公司业务发展战略
迈瑞医疗：基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案
证券之星 · 04-10
迈瑞医疗：基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案
迈瑞医疗：在泰国多家医院实现MT 8000全实验室智能化流水线的装机
证券之星 · 04-10
迈瑞医疗：在泰国多家医院实现MT 8000全实验室智能化流水线的装机
迈瑞医疗：国内业务三大产线毛利率均因产品价格下降而出现不同程度下降
证券之星 · 04-10
迈瑞医疗：国内业务三大产线毛利率均因产品价格下降而出现不同程度下降
迈瑞医疗：2025年IVD业务体量已经连续第二年成为我们的第一大产线
证券之星 · 04-10
迈瑞医疗：2025年IVD业务体量已经连续第二年成为我们的第一大产线
加载更多
公司概况
公司名称：
深圳迈瑞生物医疗电子股份有限公司
所属行业：
专用设备制造业
上市日期：
2018-10-16
主营业务：
深圳迈瑞生物医疗电子股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是体外诊断类产品、生命信息与支持类产品、医学影像类产品、新兴业务类产品、其他业务。2025年，公司自主研发的发明专利“试剂、分析血小板的方法及血液细胞分析仪”荣获第十届广东专利奖金奖。
发行价格：
48.80
{"stockData":{"symbol":"300760","market":"SZ","secType":"STK","nameCN":"迈瑞医疗","latestPrice":162.31,"timestamp":1778819829000,"preClose":161.24,"halted":0,"volume":4405314,"delay":0,"changeRate":0.0066,"floatShares":1211000000,"shares":1212000000,"eps":6.4637,"marketStatus":"午间休市","change":1.07,"latestTime":"05-15 11:30:00","open":161.11,"high":163.1,"low":160.11,"amount":713000000,"amplitude":0.0185,"askPrice":162.38,"askSize":1,"bidPrice":162.32,"bidSize":3,"shortable":0,"etf":0,"ttmEps":6.4637,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778821200000},"marketStatusCode":3,"adr":0,"adjPreClose":161.24,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":177.36,"lowLimit":145.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1212441394,"isCdr":false,"pbRate":4.87,"roa":"--","peRate":25.111005,"roe":"5.96%","epsLYR":6.7147,"committee":0.774648,"marketValue":196791000000,"turnoverRate":0.0036,"status":0,"floatMarketCap":196622000000},"requestUrl":"/m/hq/s/300760/","defaultTab":"news","newsList":[{"id":"2635752327","title":"又有国际投行发声看好中国股市，外资一季度买了啥？","url":"https://stock-news.laohu8.com/highlight/detail?id=2635752327","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635752327?lang=zh_cn&edition=full","pubTime":"2026-05-14 07:28","pubTimestamp":1778714880,"startTime":"0","endTime":"0","summary":" Wind统计数据显示，截至2026年一季度末，共有1518家A股上市公司的前十大流通股东中出现外资身影，合计持有115.25亿股，持股市值高达1946.7亿元，持股数量与市值双双大幅跃升。 与此同时，摩根士丹利、瑞银证券等多家国际知名投行近期再度发声唱多中国，认为企业盈利的强劲复苏将为这波上涨行情提供坚实支撑，并明确看好高端制造、自主可控科技及上游能源等核心主线的投资机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-05-14/doc-inhxvihs8806658.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-05-14/doc-inhxvihs8806658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688498","002475","BK4614","ASHR","600522","603268","300308","02899","300760","600031","300394","MS","BK4588","KWEB","000725","ASHS","ZIJMY","HXC","000426","600309","LU0963586101.USD","BK4585","06031","DRAG","601899","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202032","title":"迈瑞医疗：2025年净利润率下降，其中最核心的影响因素是毛利率下降了","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202032","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202032?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:21","pubTimestamp":1778664074,"startTime":"0","endTime":"0","summary":"2025 年净利润率下降，其中最核心的影响因素是毛利率下降了，这背后是因为国内业务三大产线毛利率均因产品价格下降而出现了不同程度的下降，但国际业务毛利率维持平稳。考虑到这几个因素，2026年利润率预计会有小幅下降，但下降幅度将显著收窄。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300031291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634691297","title":"迈瑞医疗 (300760) 递交香港 IPO 招股书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634691297","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634691297?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:36","pubTimestamp":1778578560,"startTime":"0","endTime":"0","summary":"FINANCIALSERVICE作为中国医疗器械绝对龙头，迈瑞医疗近日正式递交香港 IPO 招股书，冲刺港股上市。2024 年位列全球医疗器械企业第 23 名，连续五年稳居国内医疗器械营收榜首，产品覆盖全球 190 多个国家和地区，进入全球前 100 医院中的 87 家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-12/doc-inhxrshc1304555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B031J352.USD","LU2153592121.USD","LU2148510915.USD","LU1820825898.SGD","LU2348773727.SGD","LU1688375341.USD","IE0031814852.USD","LU0327786744.USD","LU1064130708.USD","LU1580142542.USD","LU0405327148.USD","LU0823426308.USD","LU1064131003.USD","IE0008368742.USD","LU1146622755.USD","LU1934453819.USD","LU0084288322.USD","SGXZ81163826.USD","LU1794554557.SGD","LU1023057109.AUD","LU1720050803.USD","LU0405327494.USD","LU2213484517.USD","LU2488822045.USD","LU2348774022.SGD","LU0823426480.USD","LU0359201612.USD","LU1655091616.SGD","LU1997245177.USD","SPCX","LU0605514214.HKD","LU1781817850.SGD","300760","LU0650527681.SGD","LU0359202008.SGD","LU2153591404.USD","IE0005HP3H50.USD","LU0594300179.USD","IPOS","LU2424517915.HKD","LU1734074674.USD","LU0594300419.USD","SGXZ49509284.SGD","IE00B031HY20.USD","BK0251","IE00B29SXG58.USD","LU1979443071.USD","LU1997245094.SGD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634473151","title":"新股消息 | 迈瑞医疗(300760.SZ)港股IPO招股书失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2634473151","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634473151?lang=zh_cn&edition=full","pubTime":"2026-05-11 10:17","pubTimestamp":1778465859,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，深圳迈瑞生物医疗电子股份有限公司于2025年11月10日所递交的港股招股书满6个月，于2026年5月10日失效，递表时华泰国际、摩根大通为其联席保荐人。据招股书，迈瑞医疗是全球领先、创新驱动的世界级医疗器械企业及医疗数智化引领者。2022年至2024年以及截至2025年6月30日止六个月，该公司收入分别约为303.66亿元、349.32亿元、367.26亿元及167.43亿元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2153591404.USD","SPCX","LU0823426308.USD","IE0005HP3H50.USD","LU1720050803.USD","LU0594300419.USD","LU1979443071.USD","IE00B031HY20.USD","LU0650527681.SGD","SGXZ81163826.USD","LU0405327494.USD","LU1734074674.USD","LU2488822045.USD","LU1820825898.SGD","BK4585","LU0327786744.USD","LU0594300179.USD","BK0251","BK4588","IE0031814852.USD","LU1934453819.USD","LU1655091616.SGD","LU1997245177.USD","LU0405327148.USD","SGXZ49509284.SGD","LU1997245094.SGD","300760","LU1064131003.USD","LU0359202008.SGD","LU1580142542.USD","LU2153592121.USD","IPOS","LU1023057109.AUD","LU1794554557.SGD","LU2148510915.USD","LU2424517915.HKD","LU0572944931.SGD","LU1064130708.USD","LU1688375341.USD","LU1781817850.SGD","LU2348774022.SGD","IE00B031J352.USD","VXUS","LU0084288322.USD","LU0605514214.HKD","LU2348773727.SGD","LU2213484517.USD","IE00B29SXG58.USD","IE0008368742.USD","LU0823426480.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634741482","title":"迈瑞医疗新注册《迈瑞数智运营管理软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634741482","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634741482?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:12","pubTimestamp":1778350332,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迈瑞医疗新注册了《迈瑞数智运营管理软件V1.0》项目的软件著作权。今年以来迈瑞医疗新注册软件著作权3个，较去年同期增加了200%。结合公司2025年年报财务数据，2025年公司在研发方面投入了35.79亿元，同比减2.38%。通过天眼查大数据分析，深圳迈瑞生物医疗电子股份有限公司共对外投资了24家企业，参与招投标项目20252次；财产线索方面有商标信息717条，专利信息6658条，著作权信息166条；此外企业还拥有行政许可1397个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00B29SXG58.USD","LU2213484517.USD","LU0084288322.USD","LU1820825898.SGD","LU1064131003.USD","LU0605514214.HKD","LU1794554557.SGD","LU2153591404.USD","LU1720050803.USD","LU2488822045.USD","LU1580142542.USD","LU1064130708.USD","LU1979443071.USD","LU2148510915.USD","LU0594300419.USD","IE0008368742.USD","LU0572944931.SGD","IE0005HP3H50.USD","LU0594300179.USD","LU0823426308.USD","LU0650527681.SGD","LU0405327148.USD","IE00B031J352.USD","LU0327786744.USD","LU1734074674.USD","LU1655091616.SGD","SGXZ81163826.USD","LU1023057109.AUD","LU2153592121.USD","159180","LU1146622755.USD","LU1997245177.USD","LU0823426480.USD","LU1688375341.USD","BK0251","LU1997245094.SGD","LU2424517915.HKD","LU0359201612.USD","LU0359202008.SGD","SGXZ49509284.SGD","LU1934453819.USD","LU1781817850.SGD","300760","IE00B031HY20.USD","LU0405327494.USD","IE0031814852.USD","LU2348773727.SGD","LU2348774022.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145576","title":"新股消息 | 迈瑞医疗(300760.SZ)拟港股IPO 证监会要求补充说明本次募集资金用途等","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145576","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633145576?lang=zh_cn&edition=full","pubTime":"2026-05-08 19:55","pubTimestamp":1778241311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月8日，中国证监会公布境外发行上市备案补充材料要求公示。其中，证监会要求迈瑞医疗补充说明本次募集资金用途是否涉及境外投资、是否已履行相关审批、核准或备案程序等情况。据港交所2025年11月10日披露，深圳迈瑞生物医疗电子股份有限公司递表港交所主板，华泰国际、摩根大通为其联席保荐人。据招股书，迈瑞医疗是全球领先、创新驱动的世界级医疗器械企业及医疗数智化引领者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","LU2153591404.USD","LU0605514214.HKD","IE0005HP3H50.USD","LU0359201612.USD","LU1023057109.AUD","SGXZ49509284.SGD","LU1794554557.SGD","LU1734074674.USD","LU1688375341.USD","IE0008368742.USD","LU1580142542.USD","LU1934453819.USD","LU1997245094.SGD","LU2348773727.SGD","LU0594300179.USD","LU2148510915.USD","LU0405327494.USD","LU1146622755.USD","LU1997245177.USD","LU0359202008.SGD","IE00B29SXG58.USD","LU0405327148.USD","LU0823426308.USD","LU0594300419.USD","LU1781817850.SGD","LU2213484517.USD","LU1720050803.USD","300760","LU2348774022.SGD","VXUS","BK4588","LU2424517915.HKD","IE00B031J352.USD","BK4585","LU0327786744.USD","LU0650527681.SGD","IE00B031HY20.USD","SPCX","LU0084288322.USD","LU2153592121.USD","IE0031814852.USD","LU1064130708.USD","LU1979443071.USD","SGXZ81163826.USD","LU2488822045.USD","LU1655091616.SGD","LU1064131003.USD","LU0823426480.USD","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632467102","title":"每周股票复盘：迈瑞医疗（300760）一季报净利降11.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632467102","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632467102?lang=zh_cn&edition=full","pubTime":"2026-05-03 02:37","pubTimestamp":1777747029,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，迈瑞医疗报收于168.4元，较上周的161.0元上涨4.6%。本周，迈瑞医疗4月30日盘中最高价报169.88元。股本股东变化截至2026年3月31日，迈瑞医疗股东户数为15.21万户，较2月28日减少409.0户，减幅0.27%。业绩披露要点迈瑞医疗2026年一季报显示，一季度主营收入83.52亿元，同比上升1.39%；归母净利润23.3亿元，同比下降11.37%；扣非净利润22.96亿元，同比下降9.25%；负债率24.77%，毛利率61.87%；财务费用2.41亿元，投资收益1023.0万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SGXZ81163826.USD","SGXZ49509284.SGD","LU1720050803.USD","300760","LU2148510915.USD","IE00B031J352.USD","IE0031814852.USD","LU0405327148.USD","IE0005HP3H50.USD","LU0594300179.USD","LU1979443071.USD","LU0084288322.USD","IE00B031HY20.USD","LU2153592121.USD","BK0251","LU1064130708.USD","LU0605514214.HKD","LU1997245094.SGD","LU0650527681.SGD","LU2213484517.USD","LU2424517915.HKD","LU2348773727.SGD","LU0572944931.SGD","IE00B29SXG58.USD","LU0327786744.USD","LU2488822045.USD","LU1146622755.USD","LU0405327494.USD","LU1655091616.SGD","LU0823426308.USD","LU0359201612.USD","LU0594300419.USD","LU1023057109.AUD","LU0359202008.SGD","LU1064131003.USD","LU1794554557.SGD","LU1688375341.USD","LU2348774022.SGD","LU2153591404.USD","LU1934453819.USD","LU1820825898.SGD","LU1781817850.SGD","LU1734074674.USD","LU0823426480.USD","LU1997245177.USD","IE0008368742.USD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632506623","title":"迈瑞医疗公布国际专利申请：“样本分析仪、光度计和测光系统”","url":"https://stock-news.laohu8.com/highlight/detail?id=2632506623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632506623?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:59","pubTimestamp":1777672754,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示迈瑞医疗（300760）公布了一项国际专利申请，专利名为“样本分析仪、光度计和测光系统”，专利申请号为PCT/CN2024/126139，国际公布日为2026年4月30日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来迈瑞医疗已公布的国际专利申请8个，较去年同期减少了20%。结合公司2025年年报财务数据，2025年公司在研发方面投入了35.79亿元，同比减2.38%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE00B031HY20.USD","LU0823426480.USD","LU1781817850.SGD","LU1146622755.USD","LU2153591404.USD","IE00B031J352.USD","LU0359202008.SGD","LU0327786744.USD","LU1688375341.USD","LU0359201612.USD","LU0594300419.USD","LU1580142542.USD","LU1997245094.SGD","LU0405327148.USD","LU1997245177.USD","LU2488822045.USD","LU0405327494.USD","LU1979443071.USD","LU2348773727.SGD","BK0251","LU0605514214.HKD","IE0031814852.USD","LU2424517915.HKD","LU2148510915.USD","LU0572944931.SGD","LU2153592121.USD","LU1655091616.SGD","IE0005HP3H50.USD","LU1734074674.USD","LU0823426308.USD","LU2348774022.SGD","SGXZ49509284.SGD","LU1064130708.USD","LU0650527681.SGD","LU1064131003.USD","LU1720050803.USD","LU1820825898.SGD","300760","LU2213484517.USD","SGXZ81163826.USD","LU0594300179.USD","LU1023057109.AUD","IE00B29SXG58.USD","LU1794554557.SGD","LU0084288322.USD","LU1934453819.USD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631101575","title":"【机构调研记录】惠升基金调研迈瑞医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2631101575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631101575?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:06","pubTimestamp":1777507585,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月29日披露的机构调研信息，惠升基金近期对1家上市公司进行了调研，相关名单如下：1）迈瑞医疗 个股亮点：公司通过微创外科业务探索手术机器人，融合腔镜、能量平台等技术积累，推出手术机器人产品，助力国产技术突破。惠升基金成立于2018年，截至目前，资产管理规模470.12亿元，排名88/212；资产管理规模470.1亿元，排名80/212；管理公募基金数51只，排名105/212；旗下公募基金经理11人，排名103/212。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000028132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0572944931.SGD","LU1023057109.AUD","LU2488822045.USD","LU2348773727.SGD","LU1064131003.USD","LU2213484517.USD","IE0008368742.USD","LU1820825898.SGD","IE00B031J352.USD","LU1064130708.USD","LU2348774022.SGD","LU1781817850.SGD","LU0650527681.SGD","LU0823426480.USD","LU0084288322.USD","LU1146622755.USD","LU1979443071.USD","LU1580142542.USD","LU1997245094.SGD","LU2153591404.USD","300760","LU0405327148.USD","LU1794554557.SGD","SGXZ49509284.SGD","LU1997245177.USD","LU1934453819.USD","IE00B29SXG58.USD","LU0823426308.USD","LU2153592121.USD","LU0327786744.USD","LU0594300179.USD","BK0251","LU0405327494.USD","LU1655091616.SGD","LU1688375341.USD","LU1720050803.USD","LU1734074674.USD","SGXZ81163826.USD","LU2148510915.USD","IE0031814852.USD","LU0594300419.USD","LU0359202008.SGD","LU0359201612.USD","IE00B031HY20.USD","LU2424517915.HKD","LU0605514214.HKD","IE0005HP3H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630430984","title":"迈瑞医疗最新公告：一季度净利润23.3亿元同比下降11.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630430984","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630430984?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:38","pubTimestamp":1777376284,"startTime":"0","endTime":"0","summary":"迈瑞医疗公告，一季度实现营业收入83.52亿元，同比增长1.39%；归属于上市公司股东的净利润23.30亿元，同比减少11.37%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800055828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629090985","title":"迈瑞医疗：公司中长期的战略方向是希望用未来十年时间进入全球前10名医疗器械公司的榜单","url":"https://stock-news.laohu8.com/highlight/detail?id=2629090985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629090985?lang=zh_cn&edition=full","pubTime":"2026-04-22 15:21","pubTimestamp":1776842469,"startTime":"0","endTime":"0","summary":"证券之星消息，迈瑞医疗04月22日在投资者关系平台上答复投资者关心的问题。公司中长期的战略方向是希望用未来十年时间进入全球前10名医疗器械公司的榜单。未来五年，迈瑞不可避免将与成熟的全球头部医疗器械企业在国际市场上正面竞争，我们要逐渐向他们看齐，这个底气来自于迈瑞深耕行业几十年所掌握的核心技术，甚至在很多方面，我们已经达到行业领先水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200030381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0572944931.SGD","LU1820825898.SGD","IE0005HP3H50.USD","LU2213484517.USD","LU0405327148.USD","BK1100","LU2348773727.SGD","LU2153591404.USD","BK1574","LU1580142542.USD","LU1734074674.USD","LU0594300179.USD","09997","LU0650527681.SGD","IE00B29SXG58.USD","LU0823426308.USD","LU1023057109.AUD","LU0327786744.USD","LU1655091616.SGD","LU1794554557.SGD","LU0359201612.USD","300760","LU0594300419.USD","LU2488822045.USD","LU2148510915.USD","LU1146622755.USD","LU1934453819.USD","LU1064130708.USD","LU1997245094.SGD","IE00B031J352.USD","IE00B031HY20.USD","SGXZ49509284.SGD","LU2153592121.USD","LU2424517915.HKD","LU0605514214.HKD","LU0359202008.SGD","09996","BK1222","LU1781817850.SGD","BK0251","LU2348774022.SGD","IE0008368742.USD","LU0084288322.USD","LU0823426480.USD","LU0405327494.USD","LU1979443071.USD","LU1688375341.USD","SGXZ81163826.USD","159883","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627134622","title":"迈瑞医疗：凭借丰富的并购整合经验降低商誉减值风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2627134622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627134622?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:51","pubTimestamp":1776343879,"startTime":"0","endTime":"0","summary":"证券之星消息，迈瑞医疗04月15日在投资者关系平台上答复投资者关心的问题。自 2008年启航全球并购之路以来，迈瑞在并购效率、标的数量、尤其是整合深度上均领先于国内同行。凭借丰富的并购整合经验，迈瑞对被并购标的进行了一系列的赋能，尽可能地保障了公司业务的可持续快速发展，同时尽可能地降低了商誉减值风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600040935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2153591404.USD","LU0823426308.USD","IE0005HP3H50.USD","LU1720050803.USD","LU0594300419.USD","LU1979443071.USD","IE00B031HY20.USD","LU0650527681.SGD","SGXZ81163826.USD","LU0405327494.USD","LU1734074674.USD","LU2488822045.USD","LU1820825898.SGD","LU0327786744.USD","LU0594300179.USD","BK0251","IE0031814852.USD","LU1934453819.USD","LU1655091616.SGD","LU1997245177.USD","LU0405327148.USD","SGXZ49509284.SGD","LU1997245094.SGD","300760","LU1064131003.USD","LU0359202008.SGD","LU1580142542.USD","LU2153592121.USD","LU1023057109.AUD","LU0359201612.USD","LU1794554557.SGD","LU2148510915.USD","LU2424517915.HKD","LU0572944931.SGD","LU1064130708.USD","LU1688375341.USD","LU1781817850.SGD","LU2348774022.SGD","IE00B031J352.USD","LU0084288322.USD","LU0605514214.HKD","LU2348773727.SGD","LU2213484517.USD","IE00B29SXG58.USD","IE0008368742.USD","LU1146622755.USD","LU0823426480.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627231315","title":"股市必读：迈瑞医疗（300760）4月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2627231315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627231315?lang=zh_cn&edition=full","pubTime":"2026-04-16 01:01","pubTimestamp":1776272476,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，迈瑞医疗报收于160.3元，下跌0.1%，换手率0.55%，成交量6.69万手，成交额10.76亿元。近期有传言，湖南县域彩超集采杀出7万“骨折价”，中标单价仅在7.06万元至9.18万元，降幅高达85％。公司目前正在申请港股上市，本次港股上市，我们尤其关注国际市场，这将是迈瑞未来大有所为的舞台。公司有信心克服短期的困难，回归稳健发展的轨道，给投资人带来一个全新的、值得信赖的、全球化的迈瑞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600001866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE0008368742.USD","LU1023057109.AUD","LU1979443071.USD","IE00B29SXG58.USD","LU2148510915.USD","LU0405327494.USD","IE0031814852.USD","BK0251","LU1934453819.USD","LU2213484517.USD","LU0823426308.USD","IE00B031HY20.USD","LU1997245094.SGD","LU1688375341.USD","LU0605514214.HKD","LU2424517915.HKD","LU0359201612.USD","LU2153592121.USD","SGXZ49509284.SGD","LU0650527681.SGD","LU0594300419.USD","LU1781817850.SGD","LU1146622755.USD","LU0572944931.SGD","LU1734074674.USD","LU0359202008.SGD","LU1820825898.SGD","LU1064130708.USD","LU2348773727.SGD","LU1997245177.USD","LU2488822045.USD","LU1720050803.USD","LU1064131003.USD","SGXZ81163826.USD","LU0084288322.USD","LU0327786744.USD","LU0823426480.USD","LU1794554557.SGD","LU0405327148.USD","LU2348774022.SGD","LU1655091616.SGD","LU1580142542.USD","LU2153591404.USD","LU0594300179.USD","300760","IE0005HP3H50.USD","IE00B031J352.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627402650","title":"迈瑞医疗：希望用未来十年时间进入全球前10名医疗器械公司的榜单","url":"https://stock-news.laohu8.com/highlight/detail?id=2627402650","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627402650?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:36","pubTimestamp":1776242168,"startTime":"0","endTime":"0","summary":"证券之星消息，迈瑞医疗04月15日在投资者关系平台上答复投资者关心的问题。公司目前正在申请港股上市，本次港股上市，我们尤其关注国际市场，这将是迈瑞未来大有所为的舞台。未来五年，我们不可避免将与成熟的全球头部医疗器械企业在国际市场上正面竞争，我们要逐渐向他们看齐，这个底气来自于迈瑞深耕行业几十年所掌握的核心技术，甚至在很多方面，我们已经达到行业领先水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500029558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0823426308.USD","LU2148510915.USD","LU0405327494.USD","LU1781817850.SGD","BK1574","LU2153591404.USD","BK1222","LU2213484517.USD","LU0327786744.USD","BK1100","LU1688375341.USD","159883","LU0594300419.USD","LU0823426480.USD","300760","LU0084288322.USD","BK1583","LU1934453819.USD","LU1064130708.USD","LU1580142542.USD","LU1997245177.USD","LU0405327148.USD","LU1979443071.USD","LU0572944931.SGD","IE0031814852.USD","IE00B031HY20.USD","LU1820825898.SGD","LU2153592121.USD","IE00B031J352.USD","LU0359201612.USD","LU0650527681.SGD","LU0594300179.USD","LU1655091616.SGD","SGXZ81163826.USD","IE0008368742.USD","LU0605514214.HKD","LU1794554557.SGD","SGXZ49509284.SGD","LU2488822045.USD","09996","LU1146622755.USD","BK0251","LU1720050803.USD","LU0359202008.SGD","LU1064131003.USD","LU1023057109.AUD","LU1734074674.USD","LU1997245094.SGD","09997","LU2424517915.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626118153","title":"迈瑞医疗：4月9日高管李朝阳增持股份合计5000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2626118153","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626118153?lang=zh_cn&edition=full","pubTime":"2026-04-10 21:01","pubTimestamp":1775826101,"startTime":"0","endTime":"0","summary":"证券之星消息，根据4月10日市场公开信息、上市公司公告及交易所披露数据整理，迈瑞医疗最新董监高及相关人员股份变动情况：2026年4月9日公司高管李朝阳共增持公司股份5000.0股，占公司总股本为0.0004%。迈瑞医疗近半年内的董监高及核心技术人员增减持详情如下：迈瑞医疗的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入1.73亿，融资余额增加；融券净流出3300.0，融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000039358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0405327494.USD","LU1146622755.USD","LU0594300179.USD","LU2488822045.USD","LU1655091616.SGD","LU2148510915.USD","SGXZ81163826.USD","LU0572944931.SGD","LU0327786744.USD","LU0650527681.SGD","LU1064130708.USD","LU1064131003.USD","LU1720050803.USD","SGXZ49509284.SGD","LU2424517915.HKD","LU0605514214.HKD","LU1781817850.SGD","LU1997245094.SGD","IE00B29SXG58.USD","LU1979443071.USD","BK0251","IE00B031J352.USD","LU0594300419.USD","LU0359201612.USD","IE00B031HY20.USD","LU2348773727.SGD","LU1688375341.USD","IE0031814852.USD","LU1580142542.USD","LU0823426480.USD","LU1997245177.USD","LU2153591404.USD","LU2213484517.USD","LU1023057109.AUD","LU1934453819.USD","LU0823426308.USD","LU1820825898.SGD","IE0008368742.USD","LU1734074674.USD","IE0005HP3H50.USD","LU2348774022.SGD","LU1794554557.SGD","LU0359202008.SGD","LU2153592121.USD","LU0084288322.USD","300760","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626528118","title":"迈瑞医疗：加快设备业务的数智化转型是公司业务发展战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2626528118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626528118?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:52","pubTimestamp":1775825576,"startTime":"0","endTime":"0","summary":"证券之星消息，迈瑞医疗04月10日在投资者关系平台上答复投资者关心的问题。迈瑞是全球领先、创新驱动的世界级医疗器械企业及数智化医疗引领者。加快设备业务的数智化转型是公司业务发展战略，公司将研发投入战略性聚焦于推进高端产品线和打造数智医疗生态系统，加强产品及数智化解决方案创新。迈瑞以客户需求驱动创新，形成多方协同和优势互补的创新氛围，坚持长期主义和聚焦价值创造的创新理念。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000039045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245094.SGD","IE0008368742.USD","BK0251","IE00B031J352.USD","LU1688375341.USD","LU1934453819.USD","LU0594300179.USD","SGXZ49509284.SGD","IE00B031HY20.USD","LU1720050803.USD","LU0572944931.SGD","LU2148510915.USD","LU0359202008.SGD","LU0650527681.SGD","LU2488822045.USD","LU0084288322.USD","LU1023057109.AUD","LU1146622755.USD","LU1979443071.USD","LU0605514214.HKD","LU1580142542.USD","LU1655091616.SGD","LU0405327494.USD","LU0405327148.USD","LU2153591404.USD","LU0359201612.USD","LU0823426308.USD","300760","LU0327786744.USD","LU1781817850.SGD","LU1064130708.USD","LU1734074674.USD","IE0031814852.USD","LU2424517915.HKD","IE0005HP3H50.USD","LU2153592121.USD","SGXZ81163826.USD","LU2213484517.USD","LU1997245177.USD","LU1794554557.SGD","LU1064131003.USD","LU1820825898.SGD","LU2348774022.SGD","LU0594300419.USD","LU2348773727.SGD","IE00B29SXG58.USD","LU0823426480.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626118329","title":"迈瑞医疗：基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2626118329","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626118329?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:52","pubTimestamp":1775825576,"startTime":"0","endTime":"0","summary":"我们在研的基于可穿戴传感器以及AI诊断和预警算法的慢病管理新方案，旨在实现对患者生命体征的持续、无感监测，弥补传统诊疗中“数据真空”的短板，并基于可穿戴设备获得的高质量数据，融合其他的多模态临床数据，通过AI算法实现高效诊断、风险分析和预警。该方案的核心优势在于，将基于院内的迈瑞的完整监护解决方案，进一步延伸到基层和家庭，构筑起围绕病人旅程的完整解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000039047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0823426308.USD","LU0405327494.USD","LU0572944931.SGD","LU0594300419.USD","IE0031814852.USD","LU0084288322.USD","IE00B031J352.USD","SGXZ49509284.SGD","SGXZ81163826.USD","IE0005HP3H50.USD","LU2213484517.USD","IE00B031HY20.USD","LU1688375341.USD","300760","LU2348773727.SGD","LU2424517915.HKD","IE0008368742.USD","LU0594300179.USD","LU1820825898.SGD","LU1979443071.USD","LU2348774022.SGD","LU0359202008.SGD","LU1064131003.USD","LU1997245177.USD","LU0327786744.USD","LU0405327148.USD","LU1997245094.SGD","IE00B29SXG58.USD","LU0650527681.SGD","LU1720050803.USD","LU1734074674.USD","LU1781817850.SGD","LU0823426480.USD","LU1146622755.USD","LU1580142542.USD","LU2153591404.USD","LU1794554557.SGD","LU0359201612.USD","LU1064130708.USD","LU1655091616.SGD","LU1934453819.USD","LU2153592121.USD","LU1023057109.AUD","LU2488822045.USD","LU2148510915.USD","LU0605514214.HKD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626211853","title":"迈瑞医疗：在泰国多家医院实现MT 8000全实验室智能化流水线的装机","url":"https://stock-news.laohu8.com/highlight/detail?id=2626211853","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626211853?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:52","pubTimestamp":1775825571,"startTime":"0","endTime":"0","summary":"证券之星消息，迈瑞医疗04月10日在投资者关系平台上答复投资者关心的问题。在泰国，迈瑞团队率先实现了血球产品线的全面突破与生化免疫基层市场的显著进展。最终在泰国多家医院实现MT 8000全实验室智能化流水线的装机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000039039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2153592121.USD","IE0005HP3H50.USD","LU1688375341.USD","LU0650527681.SGD","LU0572944931.SGD","LU0823426308.USD","LU1820825898.SGD","LU1934453819.USD","LU0823426480.USD","LU0405327494.USD","LU1997245177.USD","LU1734074674.USD","LU0359202008.SGD","LU0084288322.USD","LU0605514214.HKD","LU1146622755.USD","BK0251","LU1064131003.USD","LU1794554557.SGD","IE00B29SXG58.USD","LU1023057109.AUD","LU0594300179.USD","LU2148510915.USD","LU0327786744.USD","LU1580142542.USD","LU1997245094.SGD","LU2488822045.USD","LU0594300419.USD","LU2153591404.USD","LU2348773727.SGD","LU2213484517.USD","LU1064130708.USD","SGXZ49509284.SGD","IE0031814852.USD","IE0008368742.USD","LU1979443071.USD","LU2348774022.SGD","IE00B031HY20.USD","LU0405327148.USD","LU2424517915.HKD","SGXZ81163826.USD","LU0359201612.USD","LU1720050803.USD","LU1655091616.SGD","300760","LU1781817850.SGD","IE00B031J352.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626162123","title":"迈瑞医疗：国内业务三大产线毛利率均因产品价格下降而出现不同程度下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2626162123","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626162123?lang=zh_cn&edition=full","pubTime":"2026-04-10 15:21","pubTimestamp":1775805672,"startTime":"0","endTime":"0","summary":"2025年净利润率下降了6.57个百分点，其中最核心的影响因素是毛利率下降了2.80个百分点，这背后是因为国内业务三大产线毛利率均因产品价格下降而出现了不同程度的下降，但国际业务毛利率维持平稳。国内产品价格下降主要受医院采购预算缩减、竞争环境激烈、医保持续深化改革等因素影响。这要求我们必须实施好两个核心举措：一是占国内半壁江山的IVD 业务的“大规模、大样本量”客户突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000020212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0572944931.SGD","LU1023057109.AUD","LU2488822045.USD","LU2348773727.SGD","LU1064131003.USD","LU2213484517.USD","IE0008368742.USD","LU1820825898.SGD","IE00B031J352.USD","LU1064130708.USD","LU2348774022.SGD","LU1781817850.SGD","LU0650527681.SGD","LU0823426480.USD","LU0084288322.USD","LU1146622755.USD","LU1979443071.USD","LU1580142542.USD","LU1997245094.SGD","LU2153591404.USD","300760","LU0405327148.USD","LU1794554557.SGD","SGXZ49509284.SGD","LU1997245177.USD","LU1934453819.USD","IE00B29SXG58.USD","LU0823426308.USD","LU2153592121.USD","LU0327786744.USD","LU0594300179.USD","BK0251","LU0405327494.USD","LU1655091616.SGD","LU1688375341.USD","LU1720050803.USD","LU1734074674.USD","SGXZ81163826.USD","LU2148510915.USD","IE0031814852.USD","LU0594300419.USD","LU0359202008.SGD","LU0359201612.USD","IE00B031HY20.USD","LU2424517915.HKD","LU0605514214.HKD","IE0005HP3H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626162122","title":"迈瑞医疗：2025年IVD业务体量已经连续第二年成为我们的第一大产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2626162122","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626162122?lang=zh_cn&edition=full","pubTime":"2026-04-10 15:21","pubTimestamp":1775805671,"startTime":"0","endTime":"0","summary":"2025 年，IVD业务体量已经连续第二年成为我们的第一大产线，其中国内IVD业务不仅是收入规模第一大，且占国内收入的比重达到近一半。即便如此，从国内IVD业务收入结构来看，大部分产出仍然集中在非头部医院。国内 IVD 市场核心需要攻克的三块业务：免疫、生化和凝血，迈瑞在这三块业务的平均市占率在 2025年中约10%，截至2025 年底达到了12%。IVD 产线也将成为这3 年时间里推动国内业务加速复苏和增长的核心力量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000020210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0823426308.USD","LU0405327494.USD","LU0572944931.SGD","LU0594300419.USD","IE0031814852.USD","LU0084288322.USD","IE00B031J352.USD","SGXZ49509284.SGD","SGXZ81163826.USD","IE0005HP3H50.USD","LU2213484517.USD","IE00B031HY20.USD","LU1688375341.USD","300760","LU2348773727.SGD","LU2424517915.HKD","IE0008368742.USD","LU0594300179.USD","LU1820825898.SGD","LU1979443071.USD","LU2348774022.SGD","LU0359202008.SGD","LU1064131003.USD","LU1997245177.USD","LU0327786744.USD","LU0405327148.USD","LU1997245094.SGD","IE00B29SXG58.USD","LU0650527681.SGD","LU1720050803.USD","LU1734074674.USD","LU1781817850.SGD","LU0823426480.USD","LU1146622755.USD","LU1580142542.USD","LU2153591404.USD","LU1794554557.SGD","LU0359201612.USD","LU1064130708.USD","LU1655091616.SGD","LU1934453819.USD","LU2153592121.USD","LU1023057109.AUD","LU2488822045.USD","LU2148510915.USD","LU0605514214.HKD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778819878292,"stockEarnings":[{"period":"1week","weight":-0.0543},{"period":"1month","weight":0.0049},{"period":"3month","weight":-0.132},{"period":"6month","weight":-0.2237},{"period":"1year","weight":-0.2902},{"period":"ytd","weight":-0.1534}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0235},{"period":"6month","weight":0.047},{"period":"1year","weight":0.2274},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳迈瑞生物医疗电子股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"152082人(较上一季度减少0.27%)","perCapita":"7965股","listingDate":"2018-10-16","address":"广东省深圳市南山区高新技术产业园区科技南十二路迈瑞大厦1-4层","registeredCapital":"121244万元","survey":" 深圳迈瑞生物医疗电子股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是体外诊断类产品、生命信息与支持类产品、医学影像类产品、新兴业务类产品、其他业务。2025年，公司自主研发的发明专利“试剂、分析血小板的方法及血液细胞分析仪”荣获第十届广东专利奖金奖。","listedPrice":48.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈瑞医疗,300760,迈瑞医疗股票,迈瑞医疗股票老虎,迈瑞医疗股票老虎国际,迈瑞医疗行情,迈瑞医疗股票行情,迈瑞医疗股价,迈瑞医疗股市,迈瑞医疗股票价格,迈瑞医疗股票交易,迈瑞医疗股票购买,迈瑞医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈瑞医疗(300760)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈瑞医疗(300760)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}